Joseph J. Wolk

Mr. Wolk has been the Executive Vice President, Chief Financial Officer of Johnson & Johnson (a multinational pharmaceutical, biotechnology, and medical technologies corporation) since 2018. He is also a member of Johnson & Johnson’s (J&J) Executive Committee, and was the sponsor overseeing all capital market and operational aspects of the Company’s Consumer Health business separation into an independent, publicly traded company, Kenvue (KVUE). Joe served on the Kenvue board from 2023 to 2024 while Johnson & Johnson held an equity interest in the company. Previously, Mr. Wolk served in various leadership position at Johnson & Johnson as well as at AMETEK in a variety of accounting roles.

Mr. Wolk is a member of the Audit and Finance Committees.